miR-200c-driven Mesenchymal-To-Epithelial Transition Is a Therapeutic Target in Uterine Carcinosarcomas

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-03972-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

miR-200C Inhibits Growth of Uterine Carcinosarcoma Cells by Driving a Mesenchymal-To-Epithelial Transition

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Induction of Epithelial-Mesenchymal Transition and Down-Regulation of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2015English

Potential Therapeutic Targets of Epithelial–mesenchymal Transition in Melanoma

Cancer Letters
Cancer ResearchOncology
2017English

Uc.416 + a Promotes Epithelial-To-Mesenchymal Transition Through miR-153 in Renal Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

The Role of the miR-200 Family in Epithelial-Mesenchymal Transition

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

The Kindlin-2 Regulation of Epithelial-To-Mesenchymal Transition in Breast Cancer Metastasis Is Mediated Through miR-200b

Scientific Reports
Multidisciplinary
2018English

Epigenetic Inactivation of miR-203 as a Key Step in Neural Crest Epithelial-To-Mesenchymal Transition

Development (Cambridge)
Developmental BiologyMolecular Biology
2019English

Mesothelial-To-Mesenchymal Transition as a Possible Therapeutic Target in Peritoneal Metastasis of Ovarian Cancer

Journal of Pathology
Forensic MedicinePathology
2017English

miR-15b Promotes Epithelial-Mesenchymal Transition by Inhibiting SMURF2 in Pancreatic Cancer

International Journal of Oncology
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy